N/A
N=31
Digital Interventions in Neurorehabilitation: iTALKbetter
Stroke · Aphasia · Anomia
Bottom Line
View on ClinicalTrials.gov: NCT04566081 ↗Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcome: Primary: Accuracy Performance (%) on a Bespoke Word Retrieval Test: WRT. Two Conditions: 1. Trained Items 2. Untrained Items — 38.3; 38.4; 50.6; 43 percentage — p=0.003
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- iTalkBetter Trained Items (Behavioral); iTalkBetter Untrained Items (Behavioral)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- University College, London
- Primary completion
- Feb 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Accuracy Performance (%) on a Bespoke Word Retrieval Test: WRT. Two Conditions: 1. Trained Items 2. Untrained Items |
38.3; 38.4; 50.6; 43 | 0.003 sig |
| SECONDARY Qualitative Interviews |
— | — |
Summary
iTALKBetter will provide an app-based therapy for people with word retrieval difficulties who have had a stroke.
This study aims to test the therapy application for people with naming difficulties through a small scale item-randomized controlled trial.
Eligibility Criteria
Inclusion Criteria
- Any type of stroke but at least 6 months after onset.
- Evidence of aphasia on the Comprehensive Aphasia Test
- English as their dominant language
- Able to tolerate MRI brain scan
- Able to give informed consent
- Able to use the DNI (app)
Exclusion Criteria
- No diagnosis of developmental language disorders
- No diagnosis of severe dementia or primary progressive aphasia
- No major co-existing neurological or psychiatric diagnosis
- No contraindications to brain scanner (e.g. the presence of ferromagnetic implants or other metallic or electronic objects in the body, weight over 24 stone, claustrophobia or pregnancy).
Data sourced from ClinicalTrials.gov (NCT04566081). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.